Quarterly report pursuant to Section 13 or 15(d)

WARRANTS (Details Narrative)

v3.21.2
WARRANTS (Details Narrative) - USD ($)
 3 Months Ended 6 Months Ended
Oct. 16, 2020
Jul. 28, 2020
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Dec. 31, 2020
New Accounting Pronouncements or Change in Accounting Principle [Line Items]              
Debt face amount     $ 20,000,000   $ 20,000,000   $ 20,000,000
Share-based Payment Arrangement, Tranche One [Member]              
New Accounting Pronouncements or Change in Accounting Principle [Line Items]              
Debt face amount   $ 20,000,000          
CFF Warrant [Member]              
New Accounting Pronouncements or Change in Accounting Principle [Line Items]              
Warrants outstanding to purchase of common stock shares     1,000,000   1,000,000    
Exercise price of warrants     $ 13.20   $ 13.20    
Investment Agreement [Member] | CFF Warrant [Member]              
New Accounting Pronouncements or Change in Accounting Principle [Line Items]              
Warrants outstanding to purchase of common stock shares     1,506,206   1,506,206    
Exercise price of warrants     $ 9.46   $ 9.46    
Weighted average remaining life of warrants         4 years 1 month 9 days    
Number of warrants exercisable for common stock         500,000    
Warrant expire date     Jan. 26, 2025   Jan. 26, 2025    
Fair value of warrants issued         $ 6,215,225    
Loan Agreement [Member] | K2 HealthVentures LLC [Member]              
New Accounting Pronouncements or Change in Accounting Principle [Line Items]              
Warrants to purchase shares of common stock, exercised   86,206          
Exercise price of warrants   $ 6.96          
Loan Agreement [Member] | K2 HealthVentures LLC [Member] | Maximum [Member]              
New Accounting Pronouncements or Change in Accounting Principle [Line Items]              
Debt face amount   $ 50,000,000          
Loan Agreement [Member] | K2 Warrant [Member]              
New Accounting Pronouncements or Change in Accounting Principle [Line Items]              
Warrants to purchase shares of common stock, exercised   86,206          
Exercise price of warrants   $ 6.96          
Number of warrants exercisable for common stock   86,206          
Warrant expire date   Jul. 28, 2030          
Fair value of warrants issued   $ 472,409          
Professional Services Agreement [Member] | Warrants [Member] | Investor Relations Service Provider [Member]              
New Accounting Pronouncements or Change in Accounting Principle [Line Items]              
Warrants outstanding to purchase of common stock shares 420,000            
Exercise price of warrants $ 1.07            
Fair value of warrants issued $ 334,740            
Warrant [Member]              
New Accounting Pronouncements or Change in Accounting Principle [Line Items]              
Warrants to purchase shares of common stock, exercised     0 0 0 0